glycerol trinitrate ( nitroglycerin , in the following briefly called gtn ) plasma concentrations achieved upon application of a commercial scale produced transdermal therapeutic system containing gtn ( tts-gtn , nitroderm-tts ) were compared to those induced by 2 tts-gtn prototypes previously used for clinical trials .
C0017861
glycerol
C0017887
nitroglycerin